Association of Foxp3 regulatory gene expression with graft-versus-host disease
- PMID: 15172973
- DOI: 10.1182/blood-2004-03-1040
Association of Foxp3 regulatory gene expression with graft-versus-host disease
Abstract
Graft-versus-host disease (GVHD) is characterized by an impairment of mechanisms that underlie the development of immunologic tolerance. Although the cytokine storm associated with GVHD leads to expression of cell surface markers on both effector and regulatory T cells, regulatory CD4+ T cells that play an instrumental role in the maintenance of tolerance appear to uniquely express the Foxp3 transcriptional repressor. Foxp3 mRNA expression was significantly decreased in peripheral blood mononuclear cells from patients with either allogeneic GVHD or autologous GVHD compared with patients without GVHD. Expression of Foxp3 negatively correlated with the severity of GVHD but positively correlated with recent thymic emigrants. The results suggest that defective thymic function contributes to the impaired reconstitution of immune regulatory mechanisms following transplantation. The decrease in regulatory mechanisms after transplantation appears to provide an environment permissive to the development of GVHD.
Similar articles
-
Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation.Exp Hematol. 2005 Aug;33(8):894-900. doi: 10.1016/j.exphem.2005.05.001. Exp Hematol. 2005. PMID: 16038781
-
Induction of FoxP3+CD4+25+ regulatory T cells following hemopoietic stem cell transplantation: role of bone marrow-derived facilitating cells.J Immunol. 2007 Aug 15;179(4):2153-62. doi: 10.4049/jimmunol.179.4.2153. J Immunol. 2007. PMID: 17675474
-
Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.Biol Blood Marrow Transplant. 2004 Mar;10(3):156-70. doi: 10.1016/j.bbmt.2003.10.005. Biol Blood Marrow Transplant. 2004. PMID: 14993881
-
Modulation of graft-versus-host disease: role of regulatory T lymphocytes.Biol Blood Marrow Transplant. 2006 Jan;12(1 Suppl 2):13-21. doi: 10.1016/j.bbmt.2005.11.002. Biol Blood Marrow Transplant. 2006. PMID: 16399597 Review.
-
Immune reconstitution and tolerance after allogeneic hematopoietic stem cell transplantation.Hematology. 2003 Feb;8(1):19-26. doi: 10.1080/1024533031000072045. Hematology. 2003. PMID: 12623423 Review.
Cited by
-
Regulatory T-cell immunotherapy for allogeneic hematopoietic stem-cell transplantation.Ther Adv Hematol. 2012 Feb;3(1):29-44. doi: 10.1177/2040620711422266. Ther Adv Hematol. 2012. PMID: 23556110 Free PMC article.
-
FOXP3 expression in peripheral blood rapidly recovers and lacks correlation with the occurrence of graft-versus-host disease after allogeneic stem cell transplantation.Int J Hematol. 2007 Feb;85(2):154-62. doi: 10.1532/IJH97.06160. Int J Hematol. 2007. PMID: 17321995 Clinical Trial.
-
XBP-1s Promotes B Cell Pathogenicity in Chronic GVHD by Restraining the Activity of Regulated IRE-1α-Dependent Decay.Front Immunol. 2021 Oct 1;12:705484. doi: 10.3389/fimmu.2021.705484. eCollection 2021. Front Immunol. 2021. PMID: 34659198 Free PMC article.
-
Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine.Exp Hematol. 2007 Jul;35(7):1140-52. doi: 10.1016/j.exphem.2007.03.018. Exp Hematol. 2007. PMID: 17588483 Free PMC article.
-
'Yin-Yang' functions of transforming growth factor-beta and T regulatory cells in immune regulation.Immunol Rev. 2007 Dec;220:199-213. doi: 10.1111/j.1600-065X.2007.00565.x. Immunol Rev. 2007. PMID: 17979848 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials